Publications

    Below is a list of representative publications in recent years (For a complete list of publications please refer to Pubmed):


    1. 
    Evangelia Zvintzou, Marie Lhomme, Stella Chasapi, Serafoula Filou, Vassilis Theodoropoulos, Eva Xapapadaki, Anatol Kontush, George Spyroulias, Constantinos C. Tellis, Alexandros D. Tselepis, Caterina Constantinou and Kyriakos E. Kypreos (2017) Pleiotropic Effects of Apolipoprotein C3 on HDL Functionality and Adipose Tissue Metabolic Activity. J. Lipid Res. pii: jlr.M077925. doi: 10.1194/jlr.M077925. [PUBMED]
    2.Papachristou NI, Blair HC, Kypreos KE, Papachristou DJ. (2017) High-density lipoprotein (HDL) and bone mass. J. Endocrinol, 233(2):R95-R107 [PUBMED] [Cited by]
    3.
    Filou S, Lhomme M, Karavia EA, Kalogeropoulou C, Theodoropoulos V, Zvintzou E, Sakellaropoulos GC, Petropoulou PI, Constantinou C, Kontush A, Kypreos KE. (2016) Distinct Roles of Apolipoproteins A1 and E in the Modulation of High-Density Lipoprotein Composition and Function. Biochemistry 55 (27), 3752-3762. [PUBMED] [Cited by]
    4. Blair HC, Kalyvioti E, Papachristou NI, Tourkova IL, Syggelos SA, Deligianni D, Orkoula MG, Kontoyannis CG, Karavia EA, Kypreos KE, Papachristou DJ. (2016) Apolipoprotein A-1 regulates osteoblast and lipoblast precursor cells in mice. Lab Invest. 2016 Jul;96(7):763-72. [PUBMED] [Cited by]
    5. Caterina Constantinou, Eleni A. Karavia, Eva Xepapadaki, Peristera-Ioanna Petropoulou, Eugenia Papakosta, Marilena Karavyraki, Evangelia Zvintzou, Vassilis Theodoropoulos, Serafoula Filou, Aikaterini Hatziri, Christina Kalogeropoulou, George Panayiotakopoulos and Kyriakos E. Kypreos (2015) Advances in High Density Lipoprotein Physiology: surprises, overturns and promises. Am J Physiol Endocrinol Metab. 2016 Jan 1;310(1):E1-E14. [PUBMED] [Cited by]
    6. Eleni A. Karavia, Aikaterini Hatziri, Christina Kalogeropoulou, Nikolaos I Papachristou, Eva Xepapadaki, Caterina Constantinou, Anastasios Natsos, Peristera-Ioanna Petropoulou, Shlomo Sasson, Dionysios J Papachristou, and Kyriakos E. Kypreos (2015) Deficiency in apolipoprotein A-I ablates the pharmacological effects of metformin on plasma glucose homeostasis and hepatic lipid deposition. Eur. J. Pharmacol. 766:76-85 (10.1016/j.ejphar.2015.09.040) [PUBMED] [Cited by]
    7. Eleni A. Karavia, Nikolaos I. Papachristou, George C. Sakellaropoulos, Eva Xepapadaki, Eleni Papamichail, Peristera-Ioanna Petropoulou, Eugenia P. Papakosta, Caterina Constantinou, Ioannis Habeos, Dionysios J. Papachristou, and Kyriakos E. Kypreos (2015) Scavenger receptor class B type I regulates plasma apolipoprotein E levels and dietary lipid deposition to the liver. Biochemistry 54(36):5605-16 (10.1021/acs.biochem.5b00700) [PUBMED] [Cited by]
    8. Peristera-Ioanna Petropoulou, Jimmy F.P. Berbée, Vassilios Theodoropoulos, Aikaterini Hatziri, Panagiota Stamou, Eleni A. Karavia, Alexandros Spyridonidis, Iordanes Karagiannides and Kyriakos E. Kypreos (2015) Lack of LCAT reduces the LPS-neutralizing capacity of HDL and enhances LPS-induced inflammation in mice. BBA DIS. 1852:2106-2115. [PUBMED] [Cited by]
    9. Catherina Constantinou, Diogenis Mpatsoulis, Anastasios Natsos, Peristera-Ioanna Petropoulou, Evangelia Zvintzou, Abdulmaged M. Traish, Peter J. Voshol, Iordanes Karagiannides, Kyriakos E. Kypreos (2014) The low density lipoprotein receptor modulates the effects of hypogonadism on diet-induced obesity and related metabolic perturbations. J Lipid Res. 55(7):1434-1447.[PUBMED]  [Cited by] [FEATURED IN...]
    10. Karavia EA, Zvintzou E, Petropoulou PI, Xepapadaki E, Constantinou C, Kypreos KE. (2014) HDL quality and functionality: what can proteins and genes predict? Expert Rev Cardiovasc Ther. 12(4):521-32. [PUBMED] [Cited by]
    11. Evangelia Zvintzou, George Skroubis, Angelika Chroni, Peristera-Ioanna Petropoulou, Christina Gkolfinopoulou,George Sakellaropoulos, Donald Gantz, Ioanna Mihou, Fotios Kalfarentzos, Kyriakos E. Kypreos (2014) Effects of bariatric surgery on HDL structure and functionality: results from a prospective trial. J. Clin. Lipidol. 8(4):408-417 [PUBMED] [Cited by] [FEATURED IN...]
    12. Kyriakos E. Kypreos, Spyridon Gkizas, Loukianos S. Rallidis, Iordanis Karagiannides (2013) HDL particle functionality as a primary pharmacological target for HDL-based therapies. Biochemical Pharmacology. 85(11):1575-1578 [PUBMED] [Cited by]
    13. Angeliki Lampropoulou, Vassilis I. Zannis, Kyriakos E. Kypreos (2012) Pharmacodynamic and pharmacokinetic analysis of apoE4 [L261A, W264A, F265A, L268A, V269A], a recombinant apolipoprotein E variant with improved biological properties. Biochemical Pharmacology, 84(11):1451-8. [PUBMED] [Cited by]
    14. Irene-Eva Triantaphyllidou, Eleni Karavia, Eleni Kalyvioti, Ioannis Lilis, Kyriakos E. Kypreos, and Dionysios J. Papachristou (2012) Perturbations in ithe HDL metabolic pathway predispose to the development of osteorthritis in mice follwoing long-term exposure to westen-type diet. Osteoarthritis Cartilage. 21(2):322-330 [PUBMED] [Cited by]
    15. Eleni A. Karavia, Dionysios J. Papachristou, Kassiani Liopeta, Irene-Eva Triantafyllidou, Odyssefs Dimitrakopoulos, and Kyriakos E. Kypreos (2012) Apolipoprotein A-I modulates Processes Associated with Diet-Induced Nonalcoholic Fatty Liver Disease in Mice, Mol. Med. 18(1):901 [PUBMED] [Cited by]
    16. Kyriakos E. Kypreos (2012) HDL Quality in Atherosclerosis: can ratios between apolipoproteins of HDL be used effectively to indicate risk of premature myocardial infarction? Clin. Lipidol. 7:127-29. (Invited Editorial). [PUBMED] [Cited by]
    17. Eleni Karavia, Dionysios J. Papachristou, Ioanna Kotsikogianni, Irene-Eva Triantafyllidou, and Kyriakos E. Kypreos (2012) Lecithin:cholesterol acyltransferase modulates the severity of diet-induced nonalcoholic fatty liver disease in mice. J. Nutr. Biochem. 24(3):567-577. [PUBMED] [Cited by]
    18. Anthula E. Kavo, Loukianos Rallidis, George C. Sakellaropoulos, Stefan Lehr, Sonja Hartwig, Juergen Eckel, Polixeni Mpozatzi, Panagiota Tsikrika, and Kyriakos E. Kypreos (2012) Qualitative characteristics of HDL particles in young asymptomatic patients of an acute myocardial infarction. Atherosclerosis, 220:257-64. [PUBMED] [Cited by]
    19. Eleni Karavia, Dionysios J. Papachristou, Ioanna Kotsikogianni and Kyriakos E. Kypreos (2011) Deficiency in Apolipoprotein E has a Protective effect on Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. FEBS J, 278:3119-29. [PUBMED] [Cited by]
    20. Peristera A. Petropoulou, Donald L. Gantz, Yanan Wang, Patrick C.N. Rensen, and Kyriakos E. Kypreos (2011). The aminoterminal 1-185 domain of human apolipoprotein E suffices for the de novo biogenesis of apoE-containing HDL. Atherosclerosis, 219:116-23. [PUBMED] [Cited by]
    21. Abdul Traish and Kyriakos E. Kypreos (2010) Testosterone and Cardiovascular Disease: An Old Idea with Modern Clinical Implications, Atherosclerosis, 214:244-8. [PUBMED] [Cited by]
    22. Eirini M. Tsompanidi, Maria S. Brinkmeyer, Elisavet H. Fotiadou, Smaragda M. Giakoumi, and Kyriakos E. Kypreos (2010) HDL biogenesis and functions: Role of HDL quality and quantity in atherosclerosis. Atherosclerosis, 208: 3-9. [PUBMED] [Cited by]

    CONTACT

    Contact us
    +302610969120 +302610997940
    medpharmasec@upatras.gr
    Monday-Friday 10:00-17:00
    Saturday & Sunday: closed

    NEWSLETTER

    FOLLOW US

    LIKE US

    © Copyright 2013 - 2017 The laboratory of Prof. Kyriakos E. Kypreos at the University of Patras Medical School | Designed by IntelSoft